BioCatalyst

XTMAB-16 or Placebo — catalyst calendar

1 verified catalyst event(s) referencing XTMAB-16 or Placebo, each linked to its official source. Verified as of 2026-10-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-31
in 28d
ESTIMATED
 READOUT
Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sa
Phase 1/2 · Pulmonary Sarcoidosis
 Xentria, Inc. XTMAB-16 or Placebo ClinicalTrials.gov ↗
✓ Source-checked 2026-10-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.